Regional variation in outpatient antibiotic prescribing in Germany

Infection

Volumn 34, Issue 5, 2006, Pages 269-273

  Kern, W V ^a   De With, K ^a   Nink, K ^b   Steib Bauert, M ^a   Schroder H ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b WIdO Research Institute   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; AMOXICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; FUSIDIC ACID; LINCOSAMIDE DERIVATIVE; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLONE; QUINOLONE DERIVATIVE; ROXITHROMYCIN; STREPTOGRAMIN DERIVATIVE; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC THERAPY; ARTICLE; GEOGRAPHIC DISTRIBUTION; GERMANY; HEALTH INSURANCE; HUMAN; OUTPATIENT CARE; POPULATION RESEARCH; PRESCRIPTION;

ANTI-BACTERIAL AGENTS; DRUG PRESCRIPTIONS; DRUG UTILIZATION; GERMANY; HUMANS; OUTPATIENTS; PRESCRIPTIONS, DRUG;

EID: 33749842452     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-006-6618-y     Document Type: Article

References (26)

1. Kunin CM: Antibiotic armageddon. Clin Infect Dis 1997; 25: 240-241.
2. Guillemot D, Courvalin P: Better control of antibiotic resistance. Clin Infect Dis 2001; 33: 542-547.
3. Gonzalez A, Bischoff T, Tallent S, Sheke G, Ostrowsky B, Edmond MB, Wenzel RP: Antibiotic resistance in the community. J Hosp Infect 2003; 55: 156-157.
4. Cars O, Mölstad S, Melander A: Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851-1853.
5. Goossens H, Ferech M, Vander Stichele R, Elseviers M, the ESAC Project Group: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-587.
6. Bronzwaer SL, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen IK, Kool JL, Sprenger MJ, Degener JE: A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis 2000; 3: 278-282.
7. Garcia-Rey C, Aguilar L, Baquero F, Casal J, Martin JE: Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain. J Clin Microbiol 2002; 40: 2959-2963.
8. Kahlmeter G, Menday P, Cars O: Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection. J Antimicrob Chemother 2003; 52: 1005-1010.
9. Bergman M, Huikko S, Pihlajamaki M, Laippala P, Palva E, Huovinen P, Seppala H: Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001. Clin Infect Dis 2004; 38: 1251-1256.
10. Boccia D, Alegiani SS, Pantosti A, Moro ML, Traversa G: The geographic relationship between the use of antimicrobial drugs and the pattern of resistance for Streptococcus pneumoniae in Italy. Eur J Clin Pharmacol 2004; 60: 115-119.
11. Oteo J, Lazaro E, de Abajo FJ, Baquero F, Campos J: Antimicrobial- resistant invasive Escherichia coli, Spain. Emerg Infect Dis 2005; 11: 546-553.
12. Bouvenot G: L'observatoire national des prescriptions et consommations des médicaments: prescription et consommation des antibiotiques en ambulatoire. Bull Acad Natl Med 1999; 183: 601-609.
13. Bruinsma N, Filius PM, De Smet PA, Degener J, Endtz P, van den Bogaard AE, Stobberingh EE: Antibiotic usage and resistance in different regions of the Dutch community. Microb Drug Resist 2002; 8: 209-214.
14. Garcia EP, Bouza JM, Iscar AM, Bachiller R: Influence of population structure on the consumption of systemic antibiotics. Int J Antimicrob Agents 2005; 25: 84-88.
15. de With K, Schröder H, Meyer E, Nink K, Hoffmann S, Steib-Bauert M, Kämmerer R, Ruess S, Daschner FD, Kern WV: Antibiotikaanwendung in Deutschland im europäischen Vergleich. Dtsch Med Wochenschr 2004; 129: 1987-1992.
16. Günther J, Kern WV, Nink K, Schröder H, de With K: Solange sie noch wirken ... Analysen und Kommentare zum Antibiotikaverbrauch in Deutschland. WIdO Bonn/Universität Freiburg 2003.
17. Busse R, Riesberg A: Health care systems in transition: Germany. WHO Regional Office for Europe on behalf of the European Observatory on Health Systems and Policies, Copenhagen, 2004.
18. Fricke U, Günther J, Zawinell A: Anatomisch-therapeutisch-chemische Klassifikation mit Tagesdosen für den deutschen Arzneimittelmarkt. Methodik der ATC-Klassifikation und der DDD-Festlegung, Bonn, 2005.
19. Filippini M, Masiero G, Moschetti K: Socioeconomic determinants of regional differences in outpatient antibiotic consumption: evidence from Switzerland. Health Policy 2006; 78: 77-92.
20. Guillemot D, Bernede C: Evolution de la consommation d'antibiotiques en ville 2003-2004. Communiqué, CNAMTS, octobre 2004. http://www.caducee. net/Communiques/22102004/2210200410antibiotiques02.asp.
21. Ferech M, Joppi R, Bozzini L, Goossens H, Cornaglia G: Analysis of sales and reimbursement data on outpatient antibiotic use in Italy in 2000-2002. Abstracts of the 13th European congress of clinical microbiology and infectious diseases. Clin Microbiol Infect 2003; 9: 33.
22. Ferech M, Coenen S, Dvorakova K, Hendrickx E, Suetens C, Goossens H, Davey P: Outpatient antibiotic use in the United Kingdom expressed in DDD per 1000 inhabitants per day. Abstracts of the 45th interscience conference on antimicrobial agents and chemotherapy. ASM, Washington, 2005.
23. Matuz M, Benko R, Doro P, Hajdu E, Nagy C, Nagy E, Monnet DL, Soos G: Regional variations in community consumption of antibiotics in Hungary, 1996-2003. Br J Clin Pharmacol 2006; 61: 96-100.
24. de With K, Steib-Bauert M, Straach P, Kern WV: Is there significant regional variation in hospital antibiotic consumption in Germany? Infection 2006; 34: 274-277.
25. Harbarth S, Albrich W, Brun-Buisson C: Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. Emerg Infect Dis 2002; 8: 1460-1467.
26. Paffrath D, Schwabe U (eds): Arzneiverordnungs-Report 2005. Springer, Berlin Heidelberg New York, 2005.